Swissmedic approves IFINWIL for children with high-risk neuroblastoma

Swissmedic approved the registration of IFINWIL (eflornithine) as a monotherapy to treat paediatric patients with high-risk neuroblastoma,

Jul 9, 2025 - 06:00
Swissmedic approves IFINWIL for children with high-risk neuroblastoma
Swissmedic approved the registration of IFINWIL (eflornithine) as a monotherapy to treat paediatric patients with high-risk neuroblastoma,

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow